ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-015-2825-5
◽
2015
◽
Vol 76
(3)
◽
pp. 547-553
◽
Cited By ~ 4
Author(s):
Tomohiro Nishina
◽
Takeshi Kato
◽
Kentaro Yamazaki
◽
Takayuki Yoshino
◽
Yoshinori Miyata
◽
...
Keyword(s):
Colorectal Cancer
◽
Combination Therapy
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
Related Documents
Cited By
References
Phase II Study Of S-1, Oral Leucovorin, Oxaliplatin and Bevacizumab Combination Therapy (SOL + BV; SOLA) in Patients with Unresectable Metastatic Colorectal Cancer (MCRC)
Annals of Oncology
◽
10.1016/s0923-7534(20)32377-2
◽
2012
◽
Vol 23
◽
pp. xi131
Author(s):
Y. Miyata
◽
T. Nishina
◽
T. Kato
◽
K. Yamazaki
◽
T. Yoshino
◽
...
Keyword(s):
Colorectal Cancer
◽
Combination Therapy
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
PEAK: A randomized phase II study to compare the efficacy of panitumumab plus mFOLFOX6 to bevacizumab plus mFOLFOX6 in patients (pts) with previously untreated, unresectable metastatic colorectal cancer (mCRC) expressing wild-type KRAS.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.tps189
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. TPS189-TPS189
Author(s):
L. S. Schwartzberg
◽
V. J. Wagner
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Wild Type
◽
Randomized Phase Ii
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
6118 POSTER Randomized Phase II Study of S-1, Oral Leucovorin, and Oxaliplatin Combination Therapy (SOL) Versus MFOLFOX6 in Patients With Untreated Metastatic Colorectal Cancer (mCRC)
European Journal of Cancer
◽
10.1016/s0959-8049(11)71763-4
◽
2011
◽
Vol 47
◽
pp. S427-S428
Author(s):
H. Ojima
◽
K. Yamazaki
◽
H. Kuwano
◽
T. Otsuji
◽
T. Kato
◽
...
Keyword(s):
Colorectal Cancer
◽
Combination Therapy
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
469P Efficacy and safety of anlotinib combined with CAPEOX in first-line treatment of patients with RAS and BRAF wild-type unresectable metastatic colorectal cancer - A single-arm, multi-center, phase II study (ALTER-C-002 trial)
Annals of Oncology
◽
10.1016/j.annonc.2020.08.580
◽
2020
◽
Vol 31
◽
pp. S440
Author(s):
K. Ding
◽
Y. Liu
◽
J. Chen
◽
J. Ying
◽
Q. Xu
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Line Treatment
◽
Efficacy And Safety
◽
Wild Type
◽
First Line
◽
First Line Treatment
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis
Annals of Oncology
◽
10.1093/annonc/mdy149.021
◽
2018
◽
Vol 29
◽
pp. v108
◽
Cited By ~ 5
Author(s):
K. Lesniewski-Kmak
◽
V. Moiseenko
◽
M. Saunders
◽
H. Wasan
◽
G. Argiles
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Intensive Therapy
◽
First Line
◽
Primary Analysis
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
BMC Cancer
◽
10.1186/s12885-020-07169-6
◽
2020
◽
Vol 20
(1)
◽
Cited By ~ 1
Author(s):
Carlotta Antoniotti
◽
Beatrice Borelli
◽
Daniele Rossini
◽
Filippo Pietrantonio
◽
Federica Morano
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Initial Therapy
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-20-0426
◽
2020
◽
Vol 26
(14)
◽
pp. 3557-3564
Author(s):
Richard D. Kim
◽
Nilofer S. Azad
◽
Michael A. Morse
◽
Elizabeth Poplin
◽
Amit Mahipal
◽
...
Keyword(s):
Colorectal Cancer
◽
Monoclonal Antibody
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Chimeric Monoclonal Antibody
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
Multicenter Phase II Study of FOLFOX6 for Previously Untreated Unresectable Metastatic Colorectal Cancer
Journal of Integrative Oncology
◽
10.4172/2329-6771.1000120
◽
2014
◽
Vol 03
(02)
◽
Cited By ~ 1
Author(s):
Satoru Iwasa
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Multicenter Phase
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
TRIUMPH Study: A multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer (EPOC1602)
Annals of Oncology
◽
10.1093/annonc/mdx393.137
◽
2017
◽
Vol 28
◽
pp. v207
◽
Cited By ~ 3
Author(s):
Y. Nakamura
◽
W. Okamoto
◽
K. Sawada
◽
Y. Komatsu
◽
K. Kato
◽
...
Keyword(s):
Colorectal Cancer
◽
Combination Therapy
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Efficacy And Safety
◽
Her2 Positive
◽
Multicenter Phase
Download Full-text
A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-015-2676-0
◽
2015
◽
Vol 75
(3)
◽
pp. 569-577
◽
Cited By ~ 15
Author(s):
Kentaro Yamazaki
◽
Hiroyuki Kuwano
◽
Hitoshi Ojima
◽
Toshio Otsuji
◽
Takeshi Kato
◽
...
Keyword(s):
Colorectal Cancer
◽
Combination Therapy
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close